Author:
Walsh Megan,Fais Stefano,Spugnini Enrico Pierluigi,Harguindey Salvador,Abu Izneid Tareq,Scacco Licia,Williams Paula,Allegrucci Cinzia,Rauch Cyril,Omran Ziad
Funder
King Abdulaziz City for Sciences and Technology, Saudi Arabia
Publisher
Springer Science and Business Media LLC
Reference54 articles.
1. De Milito A, Fais S. Tumor acidity, chemoresistance and proton pump inhibitors. Future Oncol. 2005;1(6):779–86.
2. Howlader N NA, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (2013) http://seer.cancer.gov/csr/1975_2012/ .
3. Martinez-Zaguilan R, Raghunand N, Lynch RM, Bellamy W, Martinez GM, Rojas B, et al. pH and drug resistance. I. Functional expression of plasmalemmal V-type H + −ATPase in drug-resistant human breast carcinoma cell lines. Biochem Pharmacol. 1999;57(9):1037–46.
4. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74.
5. De Milito A, Marino ML, Fais S. A rationale for the use of proton pump inhibitors as antineoplastic agents. Curr Pharm Des. 2012;18(10):1395–406.
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献